Knight Therapeutics to Discuss 2024 Financial Results on Call

Author: Hannah Lewis Updated: 03-13-2025 07:48 AM

Overview of the Upcoming Conference Call

Knight Therapeutics Inc. (TSX: GUD), a prominent specialty pharmaceutical company operating across the Americas, is gearing up to release its financial results for the fourth quarter and the year ending 2024. The eagerly anticipated announcement is scheduled for Thursday, March 20, 2025, before the market opens. This will be followed by a conference call and audio webcast, opening the floor to interested stakeholders and analysts alike to tune in.

Details You Need to Know

For those keen on participating in the call, here are the essential details:

Date: March 20, 2025
Time: 8:30 a.m. ET
Phone Options: Toll-Free: 1-888-699-1199 or International: 1-416-945-7677
Webcast: Learn more at www.knighttx.com. Please note this event is a listen-only audio webcast, requiring a media player to access the broadcast.
Replay: If you miss the live event, an archived version will be available for 30 days through www.knighttx.com.

About Knight Therapeutics Inc.

Headquartered in Montreal, Canada, Knight Therapeutics Inc. focuses on developing a pipeline of specialty pharmaceuticals, emphasizing the acquisition and commercialization for Canadian and Latin American markets. Its subsidiaries in Latin America operate under distinct brands, including United Medical, Biotoscana Farma, and Laboratorio LKM. Knight Therapeutics Inc.'s shares are accessible on the Toronto Stock Exchange under the ticker GUD.

The Company’s Commitment to Health Solutions

Knight Therapeutics continues to exhibit commitment and dedication through strategic acquisitions and innovative partnerships that align with their mission to bring therapeutic solutions to the market. The company is recognized for its contributions to improving patient outcomes through effective management of pharmaceutical products tailored for diverse market needs.

Investor Relations and Contact Information

If you’re looking to connect with the team at Knight Therapeutics, here are the key individuals to reach out to:

Samira Sakhia
President & CEO
T: 514.484.4483
Email: IR@knighttx.com
Arvind Utchanah
Chief Financial Officer
T: +598.2626.2344
Email: IR@knighttx.com
Website: www.knighttx.com

Frequently Asked Questions

When is the conference call for Knight Therapeutics?

The conference call is scheduled for March 20, 2025, at 8:30 a.m. ET.

How can I listen to the conference call?

You can listen via the toll-free number or the audio webcast available at www.knighttx.com.

What is Knight Therapeutics known for?

Knight Therapeutics specializes in developing and commercializing pharmaceutical products primarily for Canada and Latin America.

Where can I find more information about Knight Therapeutics?

More information is available on their official website at www.knighttx.com.

Who can I contact for investor relations?

You may contact Samira Sakhia, the President & CEO, at 514.484.4483.

About The Author

Hi there, I'm Hannah Lewis, a writer and financial specialist of 36 years old committed to making money understandable and approachable to everyone. Years of working in the field have given me a thorough grasp of market trends, investment techniques, and economic fundamentals. My objective is to enable people, by means of understandable, useful guidance, to take charge of their financial destiny.

I have written many articles for financial blogs over my career that simplify difficult financial ideas into understandable insights. Being financially literate is a critical ability, and I am passionate about enabling people to confidently manage their financial lives. Regardless of your level of experience, my work will help you at every stage of the investment process. I appreciate being allowed to share in your success and financial expansion.

Contact Hannah Lewis privately here. Or send an email with ATTN: Hannah Lewis as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.